Atlas Trials

Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer

Clinical trial NCT00591149 · TERMINATED

Trial details

NCT number
NCT00591149
Sponsor
University of Kansas Medical Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Head and Neck CancerCarcinoma, Squamous
Start date
2007-06-01
Primary completion
2012-04-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.